Recent Press Releases

BIOGEN IDEC SECOND QUARTER 2014 REVENUES INCREASE 40% TO $2.4 BILLION; COMPANY RAISES FINANCIAL GUIDANCE FOR THE YEAR

Growth Bolstered by Increased Adoption of TECFIDERA® in New Markets Worldwide Quarter Highlights include Approval of ELOCTATETM for Hemophilia A; Positive Phase 3 Read Out for Multiple...

Biotie: Selincro enters the market in Spain

TURKU, Finland, Jul 22, 2014 (GLOBE NEWSWIRE via COMTEX) -- Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Spain. According to the terms...

Johnson & Johnson Announces $5 Billion Share Repurchase Program

NEW BRUNSWICK, N.J., July 21, 2014 /PRNewswire/ -- Johnson & Johnson JNJ +1.09% today announced that its Board of Directors has approved the repurchase of up to $5 billion of the company's...

Majority of Biotech/Pharma Employees Poised to Job Hunt

Employees in this sector indicate high interest in near-future job changes ATLANTA, July 15, 2014 /PRNewswire/ -- Employees in the U.S. biotech and pharma industries express significant interest in...

Stallergenes expands Latin American presence with acquisition of ALERGO PHARMA S.R.L. in Argentina

Stallergenes expands Latin American presence with acquisition of ALERGO PHARMA S.R.L. in Argentina Stallergenes expands Latin American presence with acquisition of ALERGO PHARMA S.R.L. in Argentina...

Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements

Corrects Allergan's False Statements Regarding Bausch + Lomb Performance LAVAL, Quebec, Jul 21, 2014 (Canada NewsWire via COMTEX) -- Valeant Pharmaceuticals International, Inc....

Allergan Reports Second Quarter 2014 Operating Results

IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2014. Allerganalso announced that its Board of Directors has declared a...

Valeant Pharmaceuticals Files Investor Presentation

Valeant Pharmaceuticals Files Investor Presentation PR Newswire 18 July 2014 Bausch + Lomb's Organic Growth 12% for the Second Quarter of 2014, over 90% Due to Volume Allergan Stockholders...

Recommended Combination of Shire PLC and AbbVie Inc.

Recommended Combination of Shire PLC and AbbVie Inc. NORTH CHICAGO, Ill., July 18, 2014 /PRNewswire/ -- Summary The Boards of AbbVie and Shire are pleased to announce that they have reached...

Zogenix, Inc. (ZGNX) Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board

Zogenix, Inc. (ZGNX) Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board SAN DIEGO, July 17, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical...

Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis

Analysis Shows Study Met Primary and All Secondary Endpoints

THOUSAND OAKS, Calif., July 17, 2014 /P

Pershing Square Releases Letter to Allergan's Board of Directors

Pershing Square to Hold Webcast on July 17 at 8:30 am EDT NEW YORK, Jul 16, 2014 (BUSINESS WIRE) -- Pershing Square Capital Management, L.P. ("Pershing Square") today announced it has sent...

FDA News Release: FDA approves new product to treat rare genetic disease

FDA News Release: FDA approves new product to treat rare genetic disease For Immediate Release: July 17, 2014 The U.S. Food and Drug Administration yesterday approved Ruconest, the first...

Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) RALEIGH, NC, LEIDEN, THE NETHERLANDS, July 17,...

GSK begins shipping 2014-15 U.S. flu vaccines

GSK begins shipping 2014-15 U.S. flu vaccines Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it...

Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook

Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook Net sales grew 2%[1] in Q2, with core operating leverage across Q2 and H1 Net sales of USD 14.6...

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries GENEVA, July 17, 2014 /PRNewswire via COMTEX/ -- GENEVA,...

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc....

New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

Study Results Presented at the Alzheimer's Association International Conference 2014

INDIANAPOLIS, July 16,